$CUTR
CUTERA INC

2024 Q4 Form 10-Q Financial Statement

#000162828024047301 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $32.50M
YoY Change -30.07%
Cost Of Revenue $30.69M
YoY Change -23.32%
Gross Profit $1.813M
YoY Change -71.92%
Gross Profit Margin 5.58%
Selling, General & Admin $33.68M
YoY Change -21.34%
% of Gross Profit 1857.53%
Research & Development $4.353M
YoY Change -5.2%
% of Gross Profit 240.1%
Depreciation & Amortization $1.669M
YoY Change -64.73%
% of Gross Profit 92.06%
Operating Expenses $38.03M
YoY Change -19.77%
Operating Profit -$36.22M
YoY Change -11.55%
Interest Expense $768.0K
YoY Change -66.43%
% of Operating Profit
Other Income/Expense, Net -$2.308M
YoY Change -26.96%
Pretax Income -$38.53M
YoY Change -12.66%
Income Tax $493.0K
% Of Pretax Income
Net Earnings -$39.02M
YoY Change -11.92%
Net Earnings / Revenue -120.06%
Basic Earnings Per Share -$1.94
Diluted Earnings Per Share -$1.94
COMMON SHARES
Basic Shares Outstanding 20.19M shares 20.13M shares
Diluted Shares Outstanding 20.15M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $57.61M
YoY Change -67.91%
Cash & Equivalents $57.61M
Short-Term Investments
Other Short-Term Assets $300.0K
YoY Change -98.51%
Inventory $56.91M
Prepaid Expenses $4.894M
Receivables $33.15M
Other Receivables $0.00
Total Short-Term Assets $160.5M
YoY Change -48.44%
LONG-TERM ASSETS
Property, Plant & Equipment $34.11M
YoY Change -57.68%
Goodwill $1.339M
YoY Change 3.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.834M
YoY Change -39.02%
Total Long-Term Assets $73.90M
YoY Change -22.47%
TOTAL ASSETS
Total Short-Term Assets $160.5M
Total Long-Term Assets $73.90M
Total Assets $234.4M
YoY Change -42.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.949M
YoY Change -74.66%
Accrued Expenses $35.97M
YoY Change -23.53%
Deferred Revenue $8.382M
YoY Change -26.98%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $672.0K
YoY Change -17.85%
Total Short-Term Liabilities $55.69M
YoY Change -39.73%
LONG-TERM LIABILITIES
Long-Term Debt $421.0M
YoY Change 0.43%
Other Long-Term Liabilities $1.095M
YoY Change 0.64%
Total Long-Term Liabilities $1.095M
YoY Change 0.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $55.69M
Total Long-Term Liabilities $1.095M
Total Liabilities $487.3M
YoY Change -6.78%
SHAREHOLDERS EQUITY
Retained Earnings -$389.8M
YoY Change 58.39%
Common Stock $136.9M
YoY Change 5.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$252.9M
YoY Change
Total Liabilities & Shareholders Equity $234.4M
YoY Change -42.35%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$39.02M
YoY Change -11.92%
Depreciation, Depletion And Amortization $1.669M
YoY Change -64.73%
Cash From Operating Activities -$24.74M
YoY Change -30.37%
INVESTING ACTIVITIES
Capital Expenditures $173.0K
YoY Change -96.34%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$173.0K
YoY Change -100.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -419.0K
YoY Change -279.06%
NET CHANGE
Cash From Operating Activities -24.74M
Cash From Investing Activities -173.0K
Cash From Financing Activities -419.0K
Net Change In Cash -25.33M
YoY Change 2126.19%
FREE CASH FLOW
Cash From Operating Activities -$24.74M
Capital Expenditures $173.0K
Free Cash Flow -$24.91M
YoY Change -38.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Expenses
OperatingExpenses
152883000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-40947000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-77453000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-98711000 usd
CY2024Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
580000 usd
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3071000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2939000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2564000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8575000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44107000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-86028000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-104835000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
493000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
167000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
449000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-39018000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-44274000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.94
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Cutera, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0492262
dei Entity Address Address Line1
EntityAddressAddressLine1
3240 Bayshore Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Brisbane
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94005
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
657-5500
dei Security12b Title
Security12bTitle
Common Stock ($0.001 par value)
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
143612000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1339000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10055000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2441000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8887000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
10430000 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
418695000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1298000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
518121000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
131496000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
162829000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108657000 usd
us-gaap Gross Profit
GrossProfit
54172000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
88591000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47448000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
38030000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
47404000 usd
us-gaap Operating Expenses
OperatingExpenses
99329000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-36217000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
561000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1726000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
8969000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
6946000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6124000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
765000 usd
us-gaap Net Income Loss
NetIncomeLoss
-105600000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.32
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19858000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19858000 shares
us-gaap Net Income Loss
NetIncomeLoss
-105600000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
94000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7834000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11575000 usd
CY2024Q3 us-gaap Assets
Assets
234418000 usd
CY2023Q4 us-gaap Assets
Assets
346291000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7949000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19829000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35972000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3386000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8382000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
55689000 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Trading Symbol
TradingSymbol
CUTR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20185926 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57614000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
1339000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10593000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
55055000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
87747000 usd
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1689000 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1494000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8397000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8703000 usd
CY2024Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
420422000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1095000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
487292000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19960622 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
20000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
136929000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
105670000 usd
us-gaap Gross Profit
GrossProfit
21876000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
63269000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13817000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19960622 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
20000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
83794000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16844000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31951000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3248000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1128000 usd
us-gaap Net Income Loss
NetIncomeLoss
-86477000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.31
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20079000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20079000 shares
us-gaap Net Income Loss
NetIncomeLoss
-86477000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
94000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-86477000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-105506000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001162461
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19251000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9878000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33150000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43121000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
56908000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
62600000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12842000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19852000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
160514000 usd
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
28664000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
16283000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
23521000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
37275000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
590000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
579000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-39018000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2308000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3160000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38525000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-11880000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-4735000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-18704000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10963000 usd
cutr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-44000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
269185000 usd
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1363000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20177717 shares
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-389823000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-303346000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-252874000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-171830000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
234418000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
346291000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
32500000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30687000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
40021000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
1813000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
6457000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18928000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
25808000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4353000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4592000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14749000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17004000 usd
CY2024Q3 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 usd
CY2023Q3 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 usd
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
9708000 usd
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1670000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
8836000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
768000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2288000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
575000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1948000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.22
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.94
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.22
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20154000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19932000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20154000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19932000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-44274000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-4000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39018000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44278000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-215671000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-26000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1841000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-252874000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-171830000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-110000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5543000 usd
us-gaap Net Income Loss
NetIncomeLoss
-86477000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-73801000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
0 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
465000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-87000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1616000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-44274000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-116085000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-15181000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
711000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
612000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3273000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6552000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
94000 usd
us-gaap Net Income Loss
NetIncomeLoss
-105600000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-116085000 usd
us-gaap Net Income Loss
NetIncomeLoss
-86477000 usd
us-gaap Net Income Loss
NetIncomeLoss
-105600000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5543000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6552000 usd
cutr Depreciation And Amortization Excluding Contract Acquisition Costs
DepreciationAndAmortizationExcludingContractAcquisitionCosts
5464000 usd
cutr Depreciation And Amortization Excluding Contract Acquisition Costs
DepreciationAndAmortizationExcludingContractAcquisitionCosts
5225000 usd
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
7085000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1726000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1670000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1048000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
62000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9740000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5488000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-232000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9755000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3259000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1781000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7010000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4352000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
472000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
5642000 usd
cutr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-83000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1845000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-390000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-82616000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103866000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1390000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30642000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
63000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
193903000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1327000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
139794000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1323000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
110000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3273000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
582000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
386000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-692000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2336000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-84635000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33592000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
143612000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
146624000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58977000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
180216000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1428000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2749000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
57000 usd
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 usd
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
6503000 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2024Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10422000 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20177717 shares
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
46478000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-39018000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-252874000 usd
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
3882000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
23467000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0 usd
cutr Inventory Transfers And Changes
InventoryTransfersAndChanges
10925000 usd
cutr Inventory Transfers And Changes
InventoryTransfersAndChanges
928000 usd
us-gaap Interest Paid Net
InterestPaidNet
6764000 usd
us-gaap Interest Paid Net
InterestPaidNet
6509000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1601000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1160000 usd
CY2024Q3 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
32 country
us-gaap Net Income Loss
NetIncomeLoss
-86500000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-162800000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reclassified the AviClear revenue category disclosed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> previously recorded as a separate revenue stream between systems and consumables revenue. Corresponding reclassifications of prior period amounts have been made in the Company's </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to conform to the current period presentation. These reclassifications had no effect on the reported net loss.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, impairment testing for long-lived assets, implicit and incremental borrowing rates related to the Company’s leases, variables used in calculating the fair value of the Company's equity awards, expected achievement of performance-based vesting criteria and management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable considerations, recoverability of deferred tax assets, and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distribution of Third-Party Products </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generated revenue from the distribution of skincare products, which were manufactured by ZO Skin Health, Inc. (“ZO”), and sold in the Japanese market. In the three and nine months ended September 30, 2024, revenue from the distribution of skincare products was nil and $4.2 million, respectively. In the nine months ended September 30, 2023, revenue from the distribution of skincare products was $24.7 million, representing 15% of the Company’s consolidated revenue. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2024, the Company and its Japanese subsidiary, Cutera KK, entered into a termination agreement (the “Termination Agreement”) with ZO USA and its Japanese subsidiary, ZO Skin Health GK (“ZO Japan” and together with ZO USA and their affiliates, “ZO”), which, among other things, (i) terminates all agreements related to the distribution by the Company of ZO’s products in Japan effective immediately, (ii) provides for the orderly transition of the distribution of ZO products to ZO, (iii) transfers certain Company employees dedicated to the distribution of ZO products to ZO, (iv) transfers </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain customer contracts related to ZO products from the Company to ZO and (v) transfers certain inventory and assets related to the distribution of ZO products from the Company to ZO. The Termination Agreement requires ZO to pay the Company $5.75 million within three business days of the execution of the Termination Agreement and make a second payment of $5.75 million, less any offsets under the Termination Agreement (including, but not limited to, 42.2% of the Company’s net revenue for sales of ZO products under the Distribution Agreement between January 1, 2024 and February 28, 2024), upon the earlier of (a) the completion the transition of regulatory and distribution activities such that ZO is able to fulfill product orders by customers in Japan, as determined by ZO and the Company, and (b) June 14, 2024. The Company received the first payment of $5.75 million on February 29, 2024, and received a second payment of $2.37 million on April 1, 2024, which was net of $1.6 million in amounts owed by Cutera. In the three months ended March 31, 2024, the Company recorded a net gain of $9.7 million resulting from the early termination proceeds received and transfer of certain assets and liabilities as gain on early termination of distribution agreement on the Company's condensed consolidated statement of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2024, the Company announced a strategic partnership with L’Oréal Japan Co. to exclusively promote, market, sell and distribute select SkinCeuticals products to medical and physician-led clinics in Japan. Under the terms of the agreement, the partnership will initially span three years, with options for renewal. Cutera plans to introduce the SkinCeuticals product line to customers in Japan during the fourth quarter of 2024 and expects the financial impact of the distribution agreement to be immaterial in 2024.</span></div>The Company generates revenue from the distribution of the Secret systems, which are manufactured by ilooda Co. Ltd. (“ilooda”). The Company is the exclusive distributor for all systems sold in the United States, Canada, the United Kingdom; the exclusive distributor for certain systems in France, and Spain; and the non-exclusive distributor for systems sold in Austria and Germany. In the nine months ended September 30, 2024, and September 30, 2023, revenue from the distribution of Secret products represented 7% and 13%, respectively, of the Company’s consolidated revenue. The Company‘s ilooda distribution agreement expires in June 30, 2026.
CY2024Q1 cutr Termination Agreement Percent Net Revenue Reduction To Termination Fee Receivable
TerminationAgreementPercentNetRevenueReductionToTerminationFeeReceivable
0.422
CY2024Q1 cutr Termination Agreement Proceeds From Termination Fees
TerminationAgreementProceedsFromTerminationFees
5750000 usd
CY2024Q2 cutr Termination Agreement Proceeds From Termination Fees
TerminationAgreementProceedsFromTerminationFees
2370000 usd
CY2024Q2 cutr Termination Agreement Offsets To Termination Fees
TerminationAgreementOffsetsToTerminationFees
1600000 usd
CY2024Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
9700000 usd
CY2024Q3 cutr Strategic Partnership Term Of Contract
StrategicPartnershipTermOfContract
P3Y
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
143600000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1400000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
40804000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
36970000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4816000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
889000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11288000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
24741000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
56908000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
62600000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
900000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
13000000 usd
CY2024Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4778000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
9501000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4894000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3819000 usd
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2870000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6307000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
300000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
225000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12842000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19852000 usd
CY2024Q3 cutr Inventory Raw Materials Noncurrent
InventoryRawMaterialsNoncurrent
16610000 usd
CY2023Q4 cutr Inventory Raw Materials Noncurrent
InventoryRawMaterialsNoncurrent
8672000 usd
CY2024Q3 cutr Inventory Work In Process Noncurrent
InventoryWorkInProcessNoncurrent
271000 usd
CY2023Q4 cutr Inventory Work In Process Noncurrent
InventoryWorkInProcessNoncurrent
2049000 usd
CY2024Q3 cutr Inventory Finished Goods Noncurrent
InventoryFinishedGoodsNoncurrent
11783000 usd
CY2023Q4 cutr Inventory Finished Goods Noncurrent
InventoryFinishedGoodsNoncurrent
5562000 usd
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
28664000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
16283000 usd
CY2024Q3 cutr Inventory Noncurrent Valuation Reserves
InventoryNoncurrentValuationReserves
40300000 usd
CY2023Q4 cutr Inventory Noncurrent Valuation Reserves
InventoryNoncurrentValuationReserves
12800000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
35451000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
47602000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
11930000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
10327000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
23521000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
37275000 usd
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
12598000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
13949000 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
3736000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1304000 usd
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3549000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2593000 usd
CY2024Q3 cutr Sales And Marketing Accruals Current
SalesAndMarketingAccrualsCurrent
3291000 usd
CY2023Q4 cutr Sales And Marketing Accruals Current
SalesAndMarketingAccrualsCurrent
4929000 usd
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2810000 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
6325000 usd
CY2024Q3 cutr Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
1456000 usd
CY2023Q4 cutr Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
5461000 usd
CY2024Q3 cutr Litigation Settlement Payable Current
LitigationSettlementPayableCurrent
0 usd
CY2023Q4 cutr Litigation Settlement Payable Current
LitigationSettlementPayableCurrent
8908000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8532000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11586000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35972000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
55055000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3010000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3104000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2593000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3254000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1596000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1076000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
4215000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3626000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1057000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1388000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3259000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
4088000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3549000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2792000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3549000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2792000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
10305000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
14007000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
11916000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13498000 usd
CY2024Q3 cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
4037000 usd
CY2023Q3 cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
5005000 usd
cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
14317000 usd
cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
15140000 usd
CY2024Q3 cutr Contract With Customer Liability Decrease From Revenue Deferred
ContractWithCustomerLiabilityDecreaseFromRevenueDeferred
1166000 usd
CY2023Q3 cutr Contract With Customer Liability Decrease From Revenue Deferred
ContractWithCustomerLiabilityDecreaseFromRevenueDeferred
405000 usd
cutr Contract With Customer Liability Decrease From Revenue Deferred
ContractWithCustomerLiabilityDecreaseFromRevenueDeferred
4317000 usd
cutr Contract With Customer Liability Decrease From Revenue Deferred
ContractWithCustomerLiabilityDecreaseFromRevenueDeferred
4902000 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2368000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5499000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9394000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
10628000 usd
CY2024Q3 cutr Contract With Customer Liability Lease Cancellations
ContractWithCustomerLiabilityLeaseCancellations
737000 usd
CY2023Q3 cutr Contract With Customer Liability Lease Cancellations
ContractWithCustomerLiabilityLeaseCancellations
0 usd
cutr Contract With Customer Liability Lease Cancellations
ContractWithCustomerLiabilityLeaseCancellations
2451000 usd
cutr Contract With Customer Liability Lease Cancellations
ContractWithCustomerLiabilityLeaseCancellations
0 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
10071000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13108000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
10071000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13108000 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.83
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10100000 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q3 cutr Costs For Extended Service Contracts
CostsForExtendedServiceContracts
1600000 usd
cutr Costs For Extended Service Contracts
CostsForExtendedServiceContracts
4800000 usd
CY2023Q3 cutr Costs For Extended Service Contracts
CostsForExtendedServiceContracts
2100000 usd
cutr Costs For Extended Service Contracts
CostsForExtendedServiceContracts
5800000 usd
cutr Revenue From Contract With Customer Typical Payment Receipt Period Post Shipment
RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment
P30D
cutr Contract With Customer Liability Training Provided With Sale Of System Period
ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod
P90D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3554537 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
186125 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2475368 shares
cutr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Elimination Of Fungible Share Ratio
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsEliminationOfFungibleShareRatio
196320 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3009733 shares
cutr Share Based Payment Arrangement Shares Granted Tax Withholding Ratio
ShareBasedPaymentArrangementSharesGrantedTaxWithholdingRatio
1.65
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2159425 shares
CY2024Q3 cutr Share Based Compensation Arrangement Number Of Grants
ShareBasedCompensationArrangementNumberOfGrants
265 grant
CY2024Q3 cutr Share Based Payment Arrangement Number Of Different Employees And Directors
ShareBasedPaymentArrangementNumberOfDifferentEmployeesAndDirectors
114 employeeanddirector
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.54
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
700000 usd
cutr Share Based Payment Arrangement Accelerated Cost Vested
ShareBasedPaymentArrangementAcceleratedCostVested
100000 usd
cutr Share Based Payment Arrangement Accelerated Cost Unvested
ShareBasedPaymentArrangementAcceleratedCostUnvested
600000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1282240 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.97
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M15D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3424252 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.73
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2475368 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.52
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2231124 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.42
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M4D
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1841000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1616000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5543000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6552000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-39018000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44274000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-86477000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-105600000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20154000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19932000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20079000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19858000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20154000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19932000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20079000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19858000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.94
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.32
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.94
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.32
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22254000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21926000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22254000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21926000 shares
CY2024Q3 cutr Income Tax Expense Benefit Including Rounding Adjustment
IncomeTaxExpenseBenefitIncludingRoundingAdjustment
500000 usd
cutr Income Tax Expense Benefit Including Rounding Adjustment
IncomeTaxExpenseBenefitIncludingRoundingAdjustment
400000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000 usd
CY2024Q3 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
CY2024Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10593000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10055000 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1094000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2516000 usd
CY2024Q3 cutr Lease Right Of Use Asset
LeaseRightOfUseAsset
11687000 usd
CY2023Q4 cutr Lease Right Of Use Asset
LeaseRightOfUseAsset
12571000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3386000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2441000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8397000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8887000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
11783000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11328000 usd
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
672000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
825000 usd
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
569000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1064000 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1241000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
1889000 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
246000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
209000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
770000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
507000 usd
CY2024Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
33000 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
23000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
112000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
61000 usd
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1083000 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
921000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
3145000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
2701000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
108000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
62000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
582000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
386000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
995000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2449000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1998000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4117000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4076000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3304000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
325000 usd
CY2024Q3 cutr Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
148000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13968000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2185000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
11783000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
239000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
697000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
424000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
16000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1376000 usd
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
135000 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1241000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.056
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.095
CY2024Q3 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P3Y
cutr Lessor Duration Of Autorenewal Features
LessorDurationOfAutorenewalFeatures
P1Y
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
3267000 usd
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
2265000 usd
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
5532000 usd
CY2024Q3 us-gaap Purchase Obligation
PurchaseObligation
1200000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
32500000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
46478000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
105670000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
162829000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
32500000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
46478000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
105670000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
162829000 usd

Files In Submission

Name View Source Status
cutr-20240930_cal.xml Edgar Link unprocessable
0001628280-24-047301-index-headers.html Edgar Link pending
0001628280-24-047301-index.html Edgar Link pending
0001628280-24-047301.txt Edgar Link pending
0001628280-24-047301-xbrl.zip Edgar Link pending
cutr-20240930.htm Edgar Link pending
cutr-20240930.xsd Edgar Link pending
cutr-20240930x10qexx311.htm Edgar Link pending
cutr-20240930x10qexx312.htm Edgar Link pending
cutr-20240930x10qexx321.htm Edgar Link pending
cutr-20240930_def.xml Edgar Link unprocessable
cutr-20240930_lab.xml Edgar Link unprocessable
cutr-20240930_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cutr-20240930_pre.xml Edgar Link unprocessable